These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9531584

  • 21. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K.
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [Abstract] [Full Text] [Related]

  • 22. Thrombopoietin and its receptor.
    Wendling F, Vainchenker W.
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [Abstract] [Full Text] [Related]

  • 23. The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis.
    Hunt P.
    Stem Cells; 1995 Nov; 13(6):579-87. PubMed ID: 8590859
    [Abstract] [Full Text] [Related]

  • 24. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.
    de Sauvage FJ, Carver-Moore K, Luoh SM, Ryan A, Dowd M, Eaton DL, Moore MW.
    J Exp Med; 1996 Feb 01; 183(2):651-6. PubMed ID: 8627177
    [Abstract] [Full Text] [Related]

  • 25. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG, Quentmeier H.
    Leukemia; 1996 Sep 01; 10(9):1405-21. PubMed ID: 8751457
    [Abstract] [Full Text] [Related]

  • 26. Thrombopoietin: understanding and manipulating platelet production.
    Kaushansky K.
    Annu Rev Med; 1997 Sep 01; 48():1-11. PubMed ID: 9046940
    [Abstract] [Full Text] [Related]

  • 27. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.
    Kimura S, Roberts AW, Metcalf D, Alexander WS.
    Proc Natl Acad Sci U S A; 1998 Feb 03; 95(3):1195-200. PubMed ID: 9448308
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS, Roberts AW, Maurer AB, Nicola NA, Dunn AR, Metcalf D.
    Stem Cells; 1996 Feb 03; 14 Suppl 1():124-32. PubMed ID: 11012212
    [Abstract] [Full Text] [Related]

  • 30. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y.
    Exp Hematol; 1997 Sep 03; 25(10):1025-33. PubMed ID: 9293899
    [Abstract] [Full Text] [Related]

  • 31. Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential.
    Papayannopoulou T.
    Cancer Chemother Pharmacol; 1996 Sep 03; 38 Suppl():S69-73. PubMed ID: 8765421
    [Abstract] [Full Text] [Related]

  • 32. Megakaryocyte development and platelet production.
    Deutsch VR, Tomer A.
    Br J Haematol; 2006 Sep 03; 134(5):453-66. PubMed ID: 16856888
    [Abstract] [Full Text] [Related]

  • 33. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
    Li J, Sabath DF, Kuter DJ.
    Cytokine; 2000 Jul 03; 12(7):835-44. PubMed ID: 10880227
    [Abstract] [Full Text] [Related]

  • 34. New insights into the regulation of megakaryocyte differentiation and platelet production derived from cloning of thrombopoietin and its receptor: surprises and unresolved questions as thrombopoietin proceeds through clinical trials.
    Jackson CW.
    J Lab Clin Med; 1998 Jun 03; 131(6):480-4. PubMed ID: 9626981
    [No Abstract] [Full Text] [Related]

  • 35. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin.
    Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS.
    Nature; 1994 Jun 16; 369(6481):568-71. PubMed ID: 8202159
    [Abstract] [Full Text] [Related]

  • 36. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M, Dowling MR, Gangatirkar P, Hodgkin PD, Kile BT, Alexander WS, Josefsson EC.
    J Thromb Haemost; 2016 Sep 16; 14(9):1882-7. PubMed ID: 27344013
    [Abstract] [Full Text] [Related]

  • 37. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis.
    Rojnuckarin P, Drachman JG, Kaushansky K.
    Blood; 1999 Aug 15; 94(4):1273-82. PubMed ID: 10438715
    [Abstract] [Full Text] [Related]

  • 38. [Regulation of megakaryopoiesis and thrombopoiesis by thrombopoietin].
    Oda A, Ikeda Y.
    Rinsho Byori; 1998 May 15; 46(5):430-4. PubMed ID: 9627493
    [Abstract] [Full Text] [Related]

  • 39. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.
    Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, Hackett NR, Crystal RG, Witte L, Hicklin DJ, Bohlen P, Eaton D, Lyden D, de Sauvage F, Rafii S.
    Nat Med; 2004 Jan 15; 10(1):64-71. PubMed ID: 14702636
    [Abstract] [Full Text] [Related]

  • 40. Consequences of GATA-1 deficiency in megakaryocytes and platelets.
    Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA.
    Blood; 1999 May 01; 93(9):2867-75. PubMed ID: 10216081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.